跳至主要内容
临床试验/NCT00567112
NCT00567112已完成1 期

An Open-Label, Randomized, Partially Fixed-Sequence, 4-Period Crossover Study to Assess the Pharmacokinetics After Administration of the DFC and OCT Formulations and the Food Effect on the OCT Formulation of MK-0941 in Patients With Type 2 Diabetes

Merck Sharp & Dohme LLC0 个研究点目标入组 18 人开始时间: 2007年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
18
主要终点
Area Under the Curve (AUC)(0-∞) for Oral Compressed Tablet (OCT) (Fasted) and Dry Filled Capsule (DFC) (Fasted)

研究概览

简要总结

A study to compare the pharmacokinetics (PK) of the dry filled capsule (DFC) & oral compressed tablet (OCT) formulations of MK-0941-009 & to assess the effect of food on the OCT formulation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females (of non-childbearing potential) between the ages of 18 to 70
  • Participants have been diagnosed with Type 2 Diabetes
  • Participants are nonsmokers for at least 6 months

排除标准

  • Participant should not be diagnosed with Type 1 diabetes
  • Participant should not be receiving insulin or PPAR gamma agonists for 12 weeks prior to study start
  • Participant has a recent history of eye infection or other inflammatory eye condition within 2 weeks prior to study start
  • Participant has been diagnosed with glaucoma or is blind
  • Participant has had trauma to one or both eyes
  • Participant has had major surgery, donated blood or participated in another clinical study in the past 4 weeks
  • Participant is a regular user of illicit drugs or has a history of drug, including alcohol, abuse in the past 6 months

研究组 & 干预措施

DFC (fasted)

Experimental

干预措施: 10 mg MK-0941 DFC (fasted) (Drug)

OCT (fasted)

Experimental

干预措施: 10 mg MK-0941 OCT (fasted) (Drug)

OCT (after meal)

Experimental

干预措施: 10 mg MK-0941 OCT (after meal) (Drug)

OCT (before meal)

Active Comparator

干预措施: 10 mg MK-0941 OCT (before meal) (Drug)

结局指标

主要结局

Area Under the Curve (AUC)(0-∞) for Oral Compressed Tablet (OCT) (Fasted) and Dry Filled Capsule (DFC) (Fasted)

时间窗: From study drug administration to 72 hours post-administration

Maximum Concentration (Cmax) for OCT (Fasted) and DFC (Fasted)

时间窗: From study drug administration to 72 hours post-administration

Time to Reach Cmax (Tmax) for OCT (Fasted) and DFC (Fasted)

时间窗: From study drug administration to 72 hours post-administration

Half Life (t½) for OCT (Fasted) and DFC (Fasted)

时间窗: From study drug administration to 72 hours post-administration

次要结局

  • AUC(0-∞) for OCT (Fasted) and OCT (After Meal)(From study drug administration to 72 hours post-administration)
  • Cmax of OCT (Fasted) and OCT (After Meal)(From study drug administration to 72 hours post-administration)
  • Tmax for OCT (Fasted) and OCT (After Meal)(From study drug administration to 72 hours post-administration)
  • t1/2 for OCT (Fasted) and OCT (After Meal)(From study drug administration to 72 hours post-administration)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验